198 related articles for article (PubMed ID: 31688455)
1. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
Carr RM; Patnaik MM
Curr Opin Hematol; 2020 Jan; 27(1):2-10. PubMed ID: 31688455
[TBL] [Abstract][Full Text] [Related]
2. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
Patnaik MM; Tefferi A
Am J Hematol; 2024 Jun; 99(6):1142-1165. PubMed ID: 38450850
[TBL] [Abstract][Full Text] [Related]
3. The role of ASXL1 in hematopoiesis and myeloid malignancies.
Asada S; Fujino T; Goyama S; Kitamura T
Cell Mol Life Sci; 2019 Jul; 76(13):2511-2523. PubMed ID: 30927018
[TBL] [Abstract][Full Text] [Related]
4. Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy.
Schnegg-Kaufmann AS; Thoms JAI; Bhuyan GS; Hampton HR; Vaughan L; Rutherford K; Kakadia PM; Lee HM; Johansson EMV; Failes TW; Arndt GM; Koval J; Lindeman R; Warburton P; Rodriguez-Meira A; Mead AJ; Unnikrishnan A; Davidson S; Polizzotto MN; Hertzberg M; Papaemmanuil E; Bohlander SK; Faridani OR; Jolly CJ; Zanini F; Pimanda JE
Blood; 2023 Mar; 141(11):1316-1321. PubMed ID: 36493342
[TBL] [Abstract][Full Text] [Related]
5. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.
Gelsi-Boyer V; Brecqueville M; Devillier R; Murati A; Mozziconacci MJ; Birnbaum D
J Hematol Oncol; 2012 Mar; 5():12. PubMed ID: 22436456
[TBL] [Abstract][Full Text] [Related]
6. Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia.
Aucagne R; Droin N; Paggetti J; Lagrange B; Largeot A; Hammann A; Bataille A; Martin L; Yan KP; Fenaux P; Losson R; Solary E; Bastie JN; Delva L
J Clin Invest; 2011 Jun; 121(6):2361-70. PubMed ID: 21537084
[TBL] [Abstract][Full Text] [Related]
7. Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia.
Weeks LD; Marinac CR; Redd R; Abel G; Lin A; Agrawal M; Stone RM; Schrag D; Ebert BL
Blood; 2022 Feb; 139(8):1246-1250. PubMed ID: 34875037
[No Abstract] [Full Text] [Related]
8. Chronic myelomonocytic leukemia: Forefront of the field in 2015.
Benton CB; Nazha A; Pemmaraju N; Garcia-Manero G
Crit Rev Oncol Hematol; 2015 Aug; 95(2):222-42. PubMed ID: 25869097
[TBL] [Abstract][Full Text] [Related]
9. Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
Baumgartner F; Baer C; Bamopoulos S; Ayoub E; Truger M; Meggendorfer M; Lenk M; Hoermann G; Hutter S; Müller H; Walter W; Müller ML; Nadarajah N; Blombery P; Keller U; Kern W; Haferlach C; Haferlach T
Blood; 2024 Mar; 143(12):1139-1156. PubMed ID: 38064663
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathology of Myeloid Neoplasms: Molecular Pattern Recognition.
Sadigh S; Kim AS
Clin Lab Med; 2024 Jun; 44(2):339-353. PubMed ID: 38821648
[TBL] [Abstract][Full Text] [Related]
11. Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis.
Inoue D; Bradley RK; Abdel-Wahab O
Genes Dev; 2016 May; 30(9):989-1001. PubMed ID: 27151974
[TBL] [Abstract][Full Text] [Related]
12. Integrated Clinical Genotype-phenotype Characteristics of STAT3-mutated Myeloid Neoplasms.
Ye MT; Zuo Z; Calin S; Ye F; He H; Kamata W; Yang Y; You MJ
Clin Cancer Res; 2024 May; ():. PubMed ID: 38767620
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of molecular markers in chronic myelomonocytic leukemia: a disease associated with several gene alterations.
Bastie JN; Aucagne R; Droin N; Solary E; Delva L
Cell Mol Life Sci; 2012 Sep; 69(17):2853-61. PubMed ID: 22415325
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcome.
Wiseman DH; Baker SM; Dongre AV; Gurashi K; Storer JA; Somervaille TC; Batta K
EBioMedicine; 2020 Aug; 58():102904. PubMed ID: 32763828
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic Syndrome: Clinical Characteristics and Significance of Preclinically Detecting Biallelic Mutations in the
Danishevich A; Chegodar A; Bodunova N; Konovalov F; Nefedova M; Kremneva N; Kurbanov N; Bilyalov A; Nikolaev S; Khatkov I; Dudina G
Life (Basel); 2024 May; 14(5):. PubMed ID: 38792657
[TBL] [Abstract][Full Text] [Related]
16. Recurrent Aortic Thromboembolism Associated With
Bukhari S; Saati A; Abuhalimeh B; Ouma G
J Investig Med High Impact Case Rep; 2024; 12():23247096231224366. PubMed ID: 38214069
[TBL] [Abstract][Full Text] [Related]
17. Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?
Cannas G; Elhamri M; Thomas X
Oncol Ther; 2024 Mar; ():. PubMed ID: 38553614
[TBL] [Abstract][Full Text] [Related]
18. Granulomatous dermatitis in the context of chronic myelomonocytic leukemia: More than just reactive infiltrates. An illustrative case report with literature review.
García-García M; Elbaile JJ; Azaceta G; Lorda M; Prieto-Torres L
J Cutan Pathol; 2024 May; ():. PubMed ID: 38711181
[TBL] [Abstract][Full Text] [Related]
19. Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias.
Duchmann M; Laplane L; Itzykson R
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638371
[TBL] [Abstract][Full Text] [Related]
20. Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant Progression.
Travaglini S; Marinoni M; Visconte V; Guarnera L
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
